Skip to main content

Name
Jordan Harry

Wed, 11/11/2020 - 11:18

Thank you Melinda for an excellent discussion, and an incredible blog post. Additionally, a sincere thanks to Dr. Richard-Carpentier for his presentation and time.
Something that stuck out to me from this presentation and personal reading, is the concept of resistance. Resistance to broad spectrum therapy is a known problem, however, as we move towards personalized therapy, the concept of drug resistance is persisting. This is an incredibly important concept for researchers to pursue, because as Dr. Richard-Carpentier pointed out, we have many novel effective drugs. Resistance could impact the efficacy of these novel therapeutics. I am personally interested in current and future research related to the use of biomarkers to determine risk of relapse and drug resistance. I think that this would not only help determine the best treatment approach for patients, but would also allow clinicians to select appropriate effective therapies sooner.

Name
Jordan Harry

Plain text

  • No HTML tags allowed.
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.